Consenso para el estudio y tratamiento de la enfermedad de Fabry. Fundación GETER

This publication has 47 references indexed in Scilit:

• Dialysis and Transplantation in Fabry Disease
  Clinical Journal of the American Society of Nephrology, 2010
• Effect of agalsidase alfa replacement therapy on fabry disease—related hypertrophic cardiomyopathy: A 12- to 36-month, retrospective, blinded echocardiographic pooled analysis
  Clinical Therapeutics, 2009
• Natural course of Fabry disease: changing pattern of causes of death in FOS – Fabry Outcome Survey
  Journal of Medical Genetics, 2009
• Agalsidase Alfa and Kidney Dysfunction in Fabry Disease
  Journal of the American Society of Nephrology, 2009
• Fabry disease in children and the effects of enzyme replacement treatment
  European Journal of Pediatrics, 2009
• Clinical usefulness of tissue Doppler imaging in predicting preclinical Fabry cardiomyopathy
  International Journal of Cardiology, 2009
• Agalsidase Alfa Slows the Decline in Renal Function in Patients with Fabry Disease
  American Journal of Nephrology, 2008
• Recommendations and guidelines for the diagnosis and treatment of Fabry nephropathy in adults
  Nature Clinical Practice Nephrology, 2008
• High Incidence of Later-Onset Fabry Disease Revealed by Newborn Screening*
  The American Journal of Human Genetics, 2006
• Ein Beitrag zur Kenntniss der Purpura haemorrhagica nodularis (Purpura papulosa haemorrhagica Hebrae)
  Archives of Dermatological Research, 1898